The couple's conflicting filming schedules got in the way throughout 2024, as they tell PEOPLE they "barely saw each other ...

Boston Red Sox first baseman Triston Casas stepped in a little bit of a public relations nightmare when he opined that Rafael ...

After Novartis and Roche grew their sales last year, the Swiss pharma giants are handing their CEOs larger compensation packages for 2024. | After Novartis and Roche grew their sales last year, the ...

Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...

With reports of Alex Bregman signing a three-year deal with the Red Sox, Thursday is a great day for Boston baseball.

Like Bio-Hermes-001, the Bio-Hermes-002 study is paving the way for improving participation by trial participants who are traditionally underrepresented in Alzheimer’s clinical research, with an ...

The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...

Helmed by Roche alums, Newleos Therapeutics is taking over four drugs dropped from the Swiss pharma’s pipeline in early 2024.

Roche's sale of InterMune and Esbriet in the US comes as Boehringer revealed its own follow-up play in the IPF, category, ...

Newleos Therapeutics is making its debut with $93.5 million aimed at developing safer and more effective neuroscience ...

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...